Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis

References

• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314.
   PubMed Web of Science ®Google Scholar
• Suh SW, Choi YS. Influence of liver fibrosis on prognosis after surgical resection for resectable single hepatocellular carcinoma. Anz J Surg. 2019;89:211–215.
   PubMed Web of Science ®Google Scholar
• Dey BK, Mueller AC, Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014;5:e944014.
   PubMedGoogle Scholar
• Chan JJ, Tay Y. Noncoding RNA: RNA regulatory networks in cancer. Int J Mol Sci. 2018;19. DOI:10.3390/ijms19051310
   Web of Science ®Google Scholar
• Li B, Mao R, Liu C, et al. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells. Life Sci. 2018;197:122–129.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang L, Chen T, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer. 2019;18:28.
   PubMed Web of Science ®Google Scholar
• Liu S, Qiu J, He G, et al. LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression. J Cancer. 2019;10:6649–6659.
   PubMed Web of Science ®Google Scholar
• Dong MM, Peng SJ, Yuan YN, et al. LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p. NEOPLASMA. 2019;66:564–575.
   PubMed Web of Science ®Google Scholar
• Lin C, Zhang S, Wang Y, et al. Functional role of a novel long noncoding RNA TTN-AS1 in esophageal squamous cell carcinoma progression and metastasis. Clin Cancer Res. 2018;24:486–498.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang Y, Dai T, et al. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1. Biomed Pharmacother. 2021;133:111030.
   PubMed Web of Science ®Google Scholar
• Liu B, Li J, Cairns MJ. Identifying miRNAs, targets and functions. Brief Bioinform. 2014;15:1–19.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, et al. MiR-139-5p: promising biomarker for cancer. Tumour Biol. 2015;36:1355–1365.
   PubMedGoogle Scholar
• Wu J, Liu L, Jin H, et al. LncSNHG3/miR-139-5p/BMI1 axis regulates proliferation, migration, and invasion in hepatocellular carcinoma. Onco Targets Ther. 2019;12:6623–6638.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? CELL. 2011;146:353–358.
   PubMed Web of Science ®Google Scholar
• Fang J, Huang C, Ke J, et al. LncRNA TTN-AS1 facilitates proliferation, invasion, and epithelial-mesenchymal transition of breast cancer cells by regulating miR-139-5p/ZEB1 axis. J CELL Biochem. 2020;121:4772–4784.
   Web of Science ®Google Scholar
• Liu X, Li Y, Wen J, et al. Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis. Biomed Pharmacother. 2020;125:109882.
   PubMed Web of Science ®Google Scholar
• Chen D, Zhou H, Liu G, et al. SPOCK1 promotes the invasion and metastasis of gastric cancer through slug-induced epithelial-mesenchymal transition. J Cell Mol Med. 2018;22:797–807.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhi X, Shi S, et al. SPOCK1 is up-regulated and promotes tumor growth via the PI3K/AKT signaling pathway in colorectal cancer. Biochem Biophys Res Commun. 2017;482:870–876.
   PubMed Web of Science ®Google Scholar
• Chen Q, Yao YT, Xu H, et al. SPOCK1 promotes tumor growth and metastasis in human prostate cancer. Drug Des Devel Ther. 2016;10:2311–2321.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen L, Chan TH, et al. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. GASTROENTEROLOGY. 2013;144:179–191.
   PubMed Web of Science ®Google Scholar
• Fu D, Lu C, Qu X, et al. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis. Aging (Albany NY). 2019;11:8374–8385.
   PubMedGoogle Scholar
• Jia Y, Duan Y, Liu T, et al. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Cell Death Dis. 2019;10:573.
   PubMed Web of Science ®Google Scholar
• Meng L, Ward AJ, Chun S, et al. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. NATURE. 2015;518:409–412.
   PubMed Web of Science ®Google Scholar
• Banday AR, Papenberg BW, Prokunina-Olsson L. When the smoke clears m(6)A from a y Chromosome-Linked lncRNA, men get an increased risk of cancer. Cancer Res. 2020;80:2718–2719.
   PubMed Web of Science ®Google Scholar
• Suarez B, Prats-Mari L, Unfried JP, et al. LncRNAs in the type i interferon antiviral response. Int J Mol Sci. 2020;21. DOI:10.3390/ijms21176447
   Web of Science ®Google Scholar
• Liu J, Li C, Jiang Y, et al. Tumor-suppressor role of miR-139-5p in endometrial cancer. Cancer Cell Int. 2018;18:51.
   PubMed Web of Science ®Google Scholar
• Chen J, Yu Y, Chen X, et al. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma. Cell Prolif. 2018;51:e12510.
   PubMed Web of Science ®Google Scholar
• Qiu G, Lin Y, Zhang H, et al. MiR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Biochem Biophys Res Commun. 2015;463:315–321.
   PubMed Web of Science ®Google Scholar
• Bradshaw AD. Diverse biological functions of the SPARC family of proteins. Int J Biochem Cell Biol. 2012;44:480–488.
   PubMed Web of Science ®Google Scholar
• Tai IT, Tang MJ. SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat. 2008;11:231–246.
   PubMed Web of Science ®Google Scholar
• Sun LR, Li SY, Guo QS, et al. SPOCK1 involvement in epithelial-to-mesenchymal transition: a new target in cancer therapy? Cancer Manag Res. 2020;12:3561–3569.
   PubMed Web of Science ®Google Scholar
• Li P, Xiao Z, Luo J, et al. MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1. J Cell Mol Med. 2019;23:2475–2488.
   PubMed Web of Science ®Google Scholar